Effects of 8-week combined training in postmenopausal women

Effects of 8-week combined training (strength and endurance) on AGRP, GH and changes in appetite and body mass in postmenopausal women

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT2016012619995N5

Enrollment

Registered

2016-02-07

Start date

2014-03-07

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Weight gain caused by menopause. Menopausal and other perimenopausal disorders

Interventions

Intervention 1: Intervention group 1: The endurance plus strength training group follow an combined training program for 8 weeks Who in the first do endurance training program and then 2 minutes of re

Intervention group 1: The endurance plus strength training group follow an combined training program for 8 weeks Who in the first do endurance training program and then 2 minutes of rest do strength t

Intervention group 2: The strength plus endurance training group follow an combined training program for 8 weeks Who in the first do strength training program and then 2 minutes of rest do endurance t

Intervention group 3: The interval training group do rotating E plus S plus E plus S plus E plus S training programs , so that's the strength and endurance program was divided into three parts.

Control group: The control group do not any regular physical activity in Daily life.

Eligibility

Sex/Gender

Female

Age

58 Years to 70 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: female; age between 58 to 70 years old; without experience of regular physical activity in one year before beginning of the study; the level of physical and mental health. Exclusion criteria: history of cardiovascular diseases, cancer, high blood pressure, diabetes, thyroid disease; addiction to any smoking, alcohol and narcotic substances; hormonal disorders; kidney or liver disease; surgery any medical intervention affecting the experimental results.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
AGRP. Timepoint: Before and after 8 weeks of intervention. Method of measurement: ELISA kit for AGRP.;GH. Timepoint: Before and after 8 weeks of intervention. Method of measurement: ELISA kit for Interleukin-6.	—

Secondary

Measure	Time frame
Changes in appetite. Timepoint: Before and after 8 weeks of intervention. Method of measurement: Appetite questionnaire with Visual Analog Scale (VAS).	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Ebrahim Banitalebi

Shahrekord University

Banitalebi@lit.sku.ac.ir+98 38 3232 4401

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026